Licence to save: a UK survey of anti-VEGF use for the eye in 2015
- PMID: 27518544
- PMCID: PMC5108014
- DOI: 10.1038/eye.2016.154
Licence to save: a UK survey of anti-VEGF use for the eye in 2015
Figures
Comment in
-
Comment on 'Licence to save: a UK survey of anti-VEGF use for the eye in 2015'.Eye (Lond). 2018 Feb;32(2):468. doi: 10.1038/eye.2017.177. Epub 2017 Aug 25. Eye (Lond). 2018. PMID: 28840854 Free PMC article. No abstract available.
References
-
- Lock D. Avastin and Lucentis: a guide through the legal maze. BMJ 2015; 350: h1377. - PubMed
-
- Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Culliford LA et al. Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet 2013; 382: 1258–1267. - PubMed
-
- Virgili G, Parravano M, Menchini F, Evans JR. Anti-vascular endothelial growth factor for diabetic macular oedema. Cochrane Database Syst Rev 2014; 10: CD007419. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
